Cardiac solution for a vascular scenario!

BACKGROUND: Ascending aortic pseudoaneurysms (AAPs) constitute a rare, albeit potentially dangerous, condition that occurs in up to 13% of patients after cardiac or aortic surgeries. For patients with a history of cardiac surgery, repeat thoracotomy poses additive risks. The high morbidity and morta...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosavi, Jamal, Ahmadi, Somaye, Firouzi, Ata, Sadeghipour, Parham, Mohebbi, Bahram, Shafe, Omid, Alizadeasl, Azin, Asadian, Sanaz, Hoseini, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
New Technologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807733/
https://www.ncbi.nlm.nih.gov/pubmed/35103878
http://dx.doi.org/10.1186/s42155-021-00280-0
_version_ 1784643747167862784
author Moosavi, Jamal
Ahmadi, Somaye
Firouzi, Ata
Sadeghipour, Parham
Mohebbi, Bahram
Shafe, Omid
Alizadeasl, Azin
Asadian, Sanaz
Hoseini, Mehran
author_facet Moosavi, Jamal
Ahmadi, Somaye
Firouzi, Ata
Sadeghipour, Parham
Mohebbi, Bahram
Shafe, Omid
Alizadeasl, Azin
Asadian, Sanaz
Hoseini, Mehran
author_sort Moosavi, Jamal
collection PubMed
description BACKGROUND: Ascending aortic pseudoaneurysms (AAPs) constitute a rare, albeit potentially dangerous, condition that occurs in up to 13% of patients after cardiac or aortic surgeries. For patients with a history of cardiac surgery, repeat thoracotomy poses additive risks. The high morbidity and mortality rates associated with the surgical management of AAPs have led to the development of transcatheter approaches. CASE REPORT: We report a case of AAP percutaneous closure at the site of aortic cannulation with an ASO device in a post-CABG 65-year-old man, who refused surgery. CONCLUSION: The use of the Amplatzer Atrial Septal Defect Occluder (ASO) device represents an acceptable alternative to surgery in treatment of Ascending aortic pseudoaneurysms.
format Online
Article
Text
id pubmed-8807733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88077332022-02-02 Cardiac solution for a vascular scenario! Moosavi, Jamal Ahmadi, Somaye Firouzi, Ata Sadeghipour, Parham Mohebbi, Bahram Shafe, Omid Alizadeasl, Azin Asadian, Sanaz Hoseini, Mehran CVIR Endovasc New Technologies BACKGROUND: Ascending aortic pseudoaneurysms (AAPs) constitute a rare, albeit potentially dangerous, condition that occurs in up to 13% of patients after cardiac or aortic surgeries. For patients with a history of cardiac surgery, repeat thoracotomy poses additive risks. The high morbidity and mortality rates associated with the surgical management of AAPs have led to the development of transcatheter approaches. CASE REPORT: We report a case of AAP percutaneous closure at the site of aortic cannulation with an ASO device in a post-CABG 65-year-old man, who refused surgery. CONCLUSION: The use of the Amplatzer Atrial Septal Defect Occluder (ASO) device represents an acceptable alternative to surgery in treatment of Ascending aortic pseudoaneurysms. Springer International Publishing 2022-02-01 /pmc/articles/PMC8807733/ /pubmed/35103878 http://dx.doi.org/10.1186/s42155-021-00280-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle New Technologies
Moosavi, Jamal
Ahmadi, Somaye
Firouzi, Ata
Sadeghipour, Parham
Mohebbi, Bahram
Shafe, Omid
Alizadeasl, Azin
Asadian, Sanaz
Hoseini, Mehran
Cardiac solution for a vascular scenario!
title Cardiac solution for a vascular scenario!
title_full Cardiac solution for a vascular scenario!
title_fullStr Cardiac solution for a vascular scenario!
title_full_unstemmed Cardiac solution for a vascular scenario!
title_short Cardiac solution for a vascular scenario!
title_sort cardiac solution for a vascular scenario!
topic New Technologies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807733/
https://www.ncbi.nlm.nih.gov/pubmed/35103878
http://dx.doi.org/10.1186/s42155-021-00280-0
work_keys_str_mv AT moosavijamal cardiacsolutionforavascularscenario
AT ahmadisomaye cardiacsolutionforavascularscenario
AT firouziata cardiacsolutionforavascularscenario
AT sadeghipourparham cardiacsolutionforavascularscenario
AT mohebbibahram cardiacsolutionforavascularscenario
AT shafeomid cardiacsolutionforavascularscenario
AT alizadeaslazin cardiacsolutionforavascularscenario
AT asadiansanaz cardiacsolutionforavascularscenario
AT hoseinimehran cardiacsolutionforavascularscenario

Ejemplares similares